Learn more

ASCENDIS PHARMA GROWTH DISORDERS AS

Overview
  • Total Patents
    71
  • GoodIP Patent Rank
    20,855
  • Filing trend
    ⇩ 85.0%
About

ASCENDIS PHARMA GROWTH DISORDERS AS has a total of 71 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and micro-structure and nano-technology are VASOGENIX PHARMACEUTICALS INC, BIOKIER INC and BEBAAS INC.

Patent filings per year

Chart showing ASCENDIS PHARMA GROWTH DISORDERS ASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hersel Ulrich 48
#2 Rau Harald 47
#3 Cleemann Felix 45
#4 Sprogøe Kennett 31
#5 Wegge Thomas 24
#6 Rasmussen Caroline Elisabeth 23
#7 Bernhard Ana 16
#8 Faltinger Frank 15
#9 Sprogoe Kennett 9
#10 Buba Annette 8

Latest patents

Publication Filing date Title
WO2020165081A1 Dry pharmaceutical formulations of cnp conjugates
US2020276270A1 Combination Therapy with Controlled-Release CNP Agonists
CN108472383A CNP agonists are discharged with the control that low NPR-C is combined
US2019015481A1 CNP prodrugs with large carrier moieties
EP3400065A1 Controlled-release cnp agonists with reduced side-effects
SG11201805028RA Controlled-release cnp agonists with increased nep stability
AU2017205693A1 Controlled-release CNP agonists with low initial NPR-B activity
CA3007979A1 Cnp prodrugs with carrier attachment at the ring moiety
MX2017008915A Cnp prodrugs.